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Abstract 
The effect of antibiotic consumption on the selection of resistant strains has been 
studied mostly by employment of conventional statistical methods. A time delay in 
effect has to be anticipated, and this was rarely taken into account in previous 
studies. Therefore, we compared distributed lags time series analysis and simple 
linear correlation in their ability to evaluate this relationship. Data on monthly 
antibiotic consumption for ciprofloxacin, piperacillin/tazobactam, carbapenems and 
cefepime and Psudomonas aeruginosa susceptibility were retrospectively collected 
for the period April 2006-July 2007. Using distributed lags analysis we identified a 
significant temporal relationship between ciprofloxacin, meropenem and cefepime 
consumption and the resistance rates of Pseudomonas aeruginosa isolates to these 
antibiotics. This effect was lagged for ciprofloxacin and cefepime [1 month (R=0.827, 
p=0.039) and 2 months (R=0.962, p=0.001), respectively] and simultaneous for 
meropenem (lag 0, R=0.876, p=0.002). Furthermore, we identified a significant 
concomitant effect of meropenem consumption on the appearance of multidrug-
resistant (resistance to ≥3 representatives of classes of antibiotics) Pseudomonas 
aeruginosa strains (lag 0, R=0.992, p<0.001).  This effect was not delayed and 
therefore it was identified both by distributed lags analysis and the Pearson’s 
correlation coefficient. Correlation coefficients analysis was not able to identify 
relationships between antibiotic consumption and bacterial resistance when the effect 
was delayed.  These results indicate that the use of diverse statistical methods can 
yield in significantly different results, thus leading to introduction of possibly 
inappropriate infection control measures. 
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1. Introduction 
The relationship between antibiotic consumption and the selection of resistant 
Pseudomonas aeruginosa (P.aeruginosa) strains has been studied extensively, 
mostly by the use of conventional statistical methods including simple and multiple 
linear regression or evaluation of correlation coefficients (Pearson r, Spearman), with 
a wide range of results [1,2,3,4]. One reason for these inconsistencies is the 
dynamics of the relationship which cannot always be discovered by the above 
mentioned methods. In the last decade time-series analysis, used particularly 
common in econometrics, is beginning to be used to evaluate this relationship [5].  
The aim of our study was to compare 2 different commonly used statistical methods 
in their ability to investigate the relationship between anti-pseudomonal antimicrobials 
consumption and resistance rates of P.aeruginosa isolates in a single ICU of a 
tertiary hospital. The statistical methods compared in the analysis of the same data 
set were simple linear correlation (Pearson r) and distributed lags time series 
analysis. Our hypothesis was that the relationship is temporal in nature and delayed, 
and that these characteristics have to be taken into account in analysis of this 
relationship by choosing appropriate analysis methods. This is of crucial importance 
for implementation of measures targeted at the specific problem, i.e. traditional 
infection control measures or restriction of use of those antibiotics that facilitate the 
emergence of resistant strains of P.aeruginosa.  
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2. Materials and methods 
2.1. Setting 
University Hospital Zagreb is a 1.700-bed tertiary hospital. The Intensive Care Unit 
(ICU) of the Department of Medicine is an 11-bed ICU with a mean of 108 
hospitalized patients per month (range 83-132) during the evaluation period. The 
evaluation was limited to a single ICU to limit the confounders associated with 
differences between various medical specialties.   
2.2. Antibiotic consumption 
Data on monthly antibiotic consumption for ciprofloxacin, piperacillin/tazobactam, 
imipenem, meropenem, and cefepime in the evaluated ICU were retrospectively 
obtained from the hospital pharmacy. The numerator used was DDD (defined daily 
dose); the denominator used was per-100 admissions. Data on admissions were 
collected from the administration office for the period April 2006- July 2007.  
2.3. Bacterial strains and susceptibility testing 
The microbiology data and the susceptibility testing results were obtained from the 
Department of Clinical Microbiology. Determination of MICs and interpretation was 
done according to CLSI criteria [6]. All clinical isolates of P.aeruginosa were included 
in the analysis. 
2.4. Statistical analysis 
Standard descriptive statistics were used to describe antimicrobial consumption and 
rates of P. aeruginosa resistance to evaluated antibiotics.  Statistical significance was 
set at p<0.05. The normality of data was verified with the Kolmogorov- Smirnov test.  
We analyzed the same data set using 2 different statistical tests: analysis of 
correlation coefficients (Pearson r) and distributed lags analysis. Only the later 
method is able to identify a dynamic (delayed) relationship between variables.  
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2.4.1. Simple linear correlation (Pearson r) 
Pearson correlation determines the extent to which values of the two variables are 
linearly related. The correlation is high if it can be "summarized" by a straight line 
called the regression line or least squares line.  The correlation coefficient (r) 
represents the linear relationship between two variables. The test of significance is 
based on the assumption that the distribution of the residual values (i.e., the 
deviations from the regression line) for the dependent variable y follows the normal 
distribution, and that the variability of the residual values is the same for all values of 
the independent variable x.  
We stress that the Pearson correlation coefficient is the same as the standardized 
coefficient for simple regression designes.   
2.4.2. Distributed Lags Time Series Analysis 
Distributed lags time series analysis is a specialized dynamic regression technique 
for examining the relationships between variables that involve some delay.  
The simplest way to describe the relationship between a dependent variable y and an 
independent variable x would be in a simple linear relationship: 
Yt = Σ βi*xt-i 
In this equation, the value of the dependent variable at time t is expressed as a linear 
function of x measured at times t, t-1, t-2, etc. Thus, the dependent variable is a 
linear function of x, and x is lagged by 1, 2, etc. time periods. The Beta weights (βi) 
can be considered slope parameters in this equation. If the weights for the lagged 
time periods are statistically significant, we can conclude that the y variable is 
predicted with the respective lag. 
As a measure of model adequacy, statistical significance of the estimated coefficients 
and the residual distribution analysis were used (analysis of histograms, normal and 
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half-normal probability plots). Furthermore, series were reviewed using the 
autocorrelation function and the partial autocorrelation function plots to exclude serial 
dependencies and to ensure appropriateness of the model.  
2.5. Hygiene practices 
There were no changes in infection control practices, disinfectants or the infection 
control team during the study period. Admission rates were stabile during the studied 
period.  
2.6. Study design 
The study is ecological in design. The previously mentioned data were collected 
retrospectively for each month of the studied period at the hospital level and 
analyzed using the appropriate statistical software:  StatSoft, Inc. (2008), Statistica 
(data analysis software system) version 8.0. www.statsoft.com.  
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3. Results 
A total of 89 non-duplicated P.aeruginosa isolates were collected from the ICU during 
the study period. The most common clinical specimens cultured were tracheal 
aspirates (51%), swabs (26%), urine (15%) and blood (6%). Thirty-seven percent of 
all P.aeruginosa isolates were multidrug resistant (resistant to representatives of 
three or more classes of antimicrobial agents). During the period of the study, the 
average observed monthly percentages of P.aeruginosa strains 
resistant/intermediately susceptible to evaluated anti-pseudomonals ranged from 
19% to 61% (Table 1). Anti-pseudomonals included for analysis in this study 
comprised 32% of the overall volume of prescribed antibiotics during the study 
period. 
Distributed lags analysis showed a significant temporal effect of the ICU use of 
ciprofloxacin, meropenem and cefepime on the susceptibility of P.aeruginosa isolates 
to ciprofloxacin, meropenem and cefepime that was delayed by 1 month, 0 months 
(simultaneous effect), and 2 months, respectively (Table 2). The changes in 
piperacillin/tazobactam and imipenem consumption did not yield in significant 
changes of P.aeruginosa susceptibility to these antibiotics. A significant relationship 
between the use of imipenem/cilastatin and the resistance to imipenem could not be 
established in this study probably due to marginal usage of imipenem/cilastatin 
during the first 7 months of the study and the preference for prescribing meropenem. 
Nevertheless, the resistance rates of P.aeruginosa strains to imipenem/cilastatin 
changed significantly in relation to meropenem consumption without a time delay (lag 
0, R=851, p=0.002), indicating a significant cross-resistance of P.aeruginosa to 
imipenem/cilastatin and meropenem. Pearson’s correlation coefficient analysis 
between meropenem consumption and resistance of P.aeruginosa isolates to 
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meropenem and imipenem nearly missed to identify this relationship as statistically 
significant (p=0.052 and 0.058, respectively) (Table 3). Since it doesn’t take the 
possible dynamic relationship into account, Pearson’s correlation coefficients 
analysis was not able to identify the relationship between ciprofloxacin and cefepime 
consumption and P.aeruginosa resistance to these antibiotics.  
Out of all anti-pseudomonals included in the study, only the variability in meropenem 
consumption resulted in significant changes of the occurrence of MDR strains of 
P.aeruginosa (Table 2). This effect was not delayed and therefore could also be 
identified both by distributed lags analysis and the Pearson’s correlation coefficient 
(Table 3). The temporal effect of ciprofloxacin, piperacillin/tazobactam and cefepime 
consumption on the occurrence of MDR P.aeruginosa strains could not be 
demonstrated in our study.   
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4. Discussion 
Available studies investigating the rapidity of selection of antimicrobial resistance 
indicate that a certain time lag between the antibiotic consumption and the 
emergence of P.aeruginosa resistance in the clinical setting should be expected, 
endorsing the use of time series analysis in investigation of this relationship [5,7]. 
Resistance of P.aeruginosa to antibiotics can be both acquired by mutations in 
chromosomal genes or horizontal transfer of resistance genes and intrinsic [8].  
Reinhardt et al. have suggested that resistant P.aeruginosa may be selected in less 
than 10 days independently of the antimicrobial class [9]. In contrast, study by 
Hocquet et al. identified various time delays (ranging 0-6 months) between 
meropenem, ciprofloxacine and cefepime use and the prevalence of clinical isolates 
of P.aeruginosa displaying an efflux based resistance to these antibiotics [10].  
Carbapenemase production is a major acquired mechanism of P.aeruginosa 
resistance to beta-lactams whose occurrence is influenced by anti-pseudomonal 
antibiotics use and length of hospital stay [11].  
In this study, we did not use all analytical possibilities of time series analysis in terms 
of modeling and forecasting (ARIMA), since this exceeded the aims of this study. We 
used distributed lags time series analysis, a dynamic regression model able to 
examine the relationships between variables that involve some delay.  
The observed P.aeruginosa resistance rates to anti-pseudomonal antibiotics were 
notably higher than the average hospital resistance rates, as well as the average 
hospital resistance rates of P.aeruginosa in Croatia [12] (Table 1).  
We stress that for the duration of this study, based on the hospital resistance rates of 
P.aeruginosa, anti-pseudomonals recommended for treatment of P.aeruginosa 
infections were piperacillin/tazobactam and cefepime. Although 
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piperacillin/tazobactam consumption plotted with the resistance of P.aeruginosa 
resulted in graphs that showed similar temporal movements, this relationship did not 
yield in statistical significance. Even though this result could be attributed to the 
relatively short study period, it corresponds with previous studies that also failed to 
demonstrate this relationship [13]. The consumption of piperacilline/tazobactam was 
lower as compared to ciprofloxacin, meropenem and cefepime, nevertheless the 
resistance of P.aeruginosa isolates to piperacillin/tazobactam remained high 
throughout the study period (Table 1) and could be attributable to high meropenem 
use since a positive relationship was identified between meropenem use and 
resistance to piperacilline/tazobactam (lag 0, R= 0.852, p=0.007) in our study as well 
as in previous studies [13,14]. If a possible dynamic relationship between variables 
was taken into account, resistance rates of P.aeruginosa to ciprofloxacin and 
cefepime could be ascribed to their consumption with a time delay of 1 month and 2 
months, respectively, thus pointing to the need for their judicious use. Ciprofloxacin is 
not considered to be an antibiotic of choice in P.aeruginosa infection. Its high use 
registered during our study is attributable to its wide application in treatment of 
abdominal and urinary tract infections and no restrictions in place to limit its usage.  
Interestingly, although the pattern of cefepime use was significantly related to the 
pattern of P.aeruginosa susceptibility to cefepime, and its consumption was high, it 
remained the anti-pseudomonal agent with the best susceptibility profile to 
P.aeruginosa throughout the study period.  
Meropenem was considered as the preferred carbapenem in treating serious 
infections in the evaluated ICU. Changes in P.aeruginosa resistance rates to both 
meropenem and imipenem were attributable to changes in meropenem consumption. 
In addition, without an identified delay in effect, meropenem showed the “fastest” 
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pressure for selection of P.aeruginosa strains resistant to meropenem (and 
imipenem) as well as for selection of MDR strains of P.aeruginosa. This simultaneous 
effect was identified by both statistical analysis methods, consequently pointing to a 
restriction of its use as a required measure of resistance control.  
The results imply that more rigorous control of anti-pseudomonal antibiotics 
prescription is warranted, and that the preferred anti-pseudomonal antibiotic in the 
evaluated ICU should be cefepime.  
4.1. Interpretation of results- Pearson’s correlation coefficient 
Using the Pearson’s correlation coefficients analysis we identified only the use of 
meropenem as being significantly correlated to P.aeruginosa resistance. 
Subsequently, we could conclude that the anti-pseudomonal antimicrobials 
consumption was not the main problem in the evaluated ICU, with the possible 
exception of meropenem, but that the main problems is probably the insufficient 
implementation of basic infectious control measures and cross-transmission. 
Consequently, the focus would be set on more rigorous implementation of infection 
control measures, without a particular need to readjust the use of anti-pseudomonal 
antibiotics, except for required restrictions in meropenem use.  
4.2. Interpretation of results- distributed lags analysis 
By the use of distributed lags analysis we identified changes in ciprofloxacin, 
cefepime and meropenem consumption as being significantly temporally related to 
changes in P.aeruginosa resistance. According to the results of this analysis, we 
would conclude that the main problem in the evaluated ICU is most probably the 
imprudent use of anti-pseudomonal antibiotics. Consequently, the focus needs to be 
set on more restricted and controlled use of all anti-pseudomonal antibiotics in 
addition to the continuous implementation of basic infection control measures.  
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This study is ecological in design and it cannot be used to determine whether 
individual patients with resistant isolates of P.aeruginosa were actually exposed to 
the relevant antibiotic, other antibiotics or other risk factors associated with 
resistance, which is an important limitation. 
Although the problem of antimicrobial resistance was reported to be primarily 
ecological, using only ecological data may underestimate the impact of antibiotic 
misuse [15]. The correlation between antibiotic usage and bacterial resistance is 
complex, thus complete understanding and evaluation of these mechanisms is not 
possible without the inclusion of both ecological and patient level data to allow 
adjustments for confounding. Since patient level data were not included in the study, 
we were not able to extract and include only ICU-acquired isolates of P.aeruginosa in 
the analysis. Therefore, the possible impact of confounding factors outside the 
evaluated ICU could not be assessed (e.g. antibiotic use outside the ICU). 
Another limitation of this study is the lack of differentiation between colonization and 
infection. However, the primary endpoint in our study was not the change in the 
incidence of P.aeruginosa infection, but the change in the overall susceptibility of 
P.aeruginosa isolates to prescribed anti-pseudomonal antibiotics.  
This study is limited to P.aeruginosa, therefore similar conclusions for other 
pathogens cannot be made.   
Despite aforementioned biases, we believe that the presented approach was able to 
demonstrate the necessity to statistically account for time delays when analyzing the 
relationship between antibiotics consumption and the emergence of bacterial 
resistance.    
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5. Conclusion 
We showed that the use of diverse statistical methods can yield in significantly 
different results, thus leading to commencement of different and possibly 
inappropriate infection control measures. Due to mentioned limitation of this study, 
the evaluation of this approach should be followed by more detailed analyses, with 
inclusion of more data points and, if possible, patient level data.   
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Table 1. Average percentage of ICU anti-pseudomonal antibiotic consumption and 
P.aeruginosa resistance rates during the study period.  
 
Antibiotic Antibiotic 
consumption 
P.aeruginosa resistance rates 
ICU 
(%)a 
ICU  
(%)b 
UH Zagreb 
(%)c 
Croatia 
(%)d 
ciprofloxacin 8.6 61 36 22 
piperacillin/tazobactam 5.2 48 22 20 
imipenem 2.2 57 32 11 
meropenem 8.9 55 30 11 
cefepime 7.2 19 17 8 
a % of overall ICU antibiotic consumption (April 2006- July 2007)  
b monthly average ICU P.aeruginosa resistance rates (April 2006- July 2007)  
c average hospital P.aeruginosa resistance rates in 2007 
d average resistance of hospital strains of P.aeruginosa in Croatia in 2007 
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Table 2. Distributed lags analysis between the dependent variable (monthly 
percentage of P.aeruginosa isolates resistant to the target antibiotic/monthly 
percentage of MDR isolates of P.aeruginosa) and the independent variable 
(antimicrobial consumption expressed as DDD/100-admissions). 
 
Antibiotic 
consumption 
(DDDs/100-
admissions) 
P.aeruginosa isolates resistant to the target antibiotic 
 
Regression 
coefficient 
Standard 
Error 
t Laga P value 
Ciprofloxacin 
 
0.827 0.349 2.371 1 0.039 
Piperacillin/tazobactam 
 
- - - 
None 
identified 
- 
Imipenem 
 
- - - 
None 
identified 
- 
Meropenem 
Meropenemb 
0.876 
0.879 
0.277 
0.275 
3.937 
3.922 
0 
0 
0.002 
0.002 
Cefepime 
 
0.962 0.041 5.035 2 0.001 
 
MDR isolates of P.aeruginosa resistant to the target 
antibiotic 
 
Ciprofloxacin 
 
- - - 
None 
identified 
- 
Piperacillin/tazobactam 
 
- - - 
None 
identified 
- 
Imipenem 
 
- - - 
None 
identified 
- 
Meropenem 
 
0.992 0.221 4.492 0 0.0006 
Cefepime 
 
- -  
None 
identified 
- 
aonly the most significant lags are mentioned 
bmeropenem consumption vrs P.aeruginosa resistance to imipenem 
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Table 3. Pearson's correlation coefficients (r) between the dependent variable 
(monthly percentage of P.aeruginosa isolates resistant to the index antibiotic/MDR 
P.aeruginosa isolates) and the independent variable (antimicrobial consumption 
expressed as DDD/100-admissions). 
 
Antibiotic 
consumption  
(DDDs/100-
admissions) 
P.aeruginosa isolates 
resistant to the target 
antibiotic 
MDR P.aeruginosa isolates 
r p-value r P value 
Ciprofloxacin  
 
- 0.266 0.319 - 0.353 0.181 
Piperacillin/tazobactam 
 
- 0.313 0.238 - 0.139 0.702 
Imipenem 
 
- 0.181 0.504 - 0.181 0.504 
Meropenem 
Meropenema 
0.495  
0.483 
0.052 
0.058 
0.659 0.005 
Cefepime 
 
0.287 0.281 0.400 0.125 
acorrelation between the meropenem consumption and resistance rates of 
P.aeruginosa to imipenem 
 
